COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Monika Gawalko; Agnieszka Kaplon-Cieslicka; Mathias Hohl; Dobromir Dobrev; Dominik Linz

doi:10.1016/j.ijcha.2020.100631

COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications

Monika Gawalko^*, Agnieszka Kaplon-Cieslicka, Mathias Hohl, Dobromir Dobrev, Dominik Linz

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

Original language	English
Article number	100631
Number of pages	8
Journal	IJC Heart & Vasculature
Volume	30
DOIs	https://doi.org/10.1016/j.ijcha.2020.100631
Publication status	Published - Oct 2020

Keywords

Anticoagulation
Arrhythmia
Inflammasome
Remote monitoring
Thromboembolic risk
OBSTRUCTIVE RESPIRATORY EVENTS
CRITICALLY-ILL PATIENTS
INFLAMMATION
PROMOTES
RECEPTOR
OUTCOMES
ACE2
ARRHYTHMIAS
DYSFUNCTION
AMIODARONE

Access to Document

10.1016/j.ijcha.2020.100631Licence: CC BY-NC-ND

Cite this

@article{432e7dd943c34eaa8b5a0dd3fca4e2d1,

title = "COVID-19 associated atrial fibrillation: Incidence, putative mechanisms and potential clinical implications",

keywords = "Anticoagulation, Arrhythmia, Inflammasome, Remote monitoring, Thromboembolic risk, OBSTRUCTIVE RESPIRATORY EVENTS, CRITICALLY-ILL PATIENTS, INFLAMMATION, PROMOTES, RECEPTOR, OUTCOMES, ACE2, ARRHYTHMIAS, DYSFUNCTION, AMIODARONE",

author = "Monika Gawalko and Agnieszka Kaplon-Cieslicka and Mathias Hohl and Dobromir Dobrev and Dominik Linz",

year = "2020",

month = oct,

doi = "10.1016/j.ijcha.2020.100631",

language = "English",

volume = "30",

journal = "IJC Heart and Vasculature",

issn = "2352-9067",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - COVID-19 associated atrial fibrillation

T2 - Incidence, putative mechanisms and potential clinical implications

AU - Gawalko, Monika

AU - Kaplon-Cieslicka, Agnieszka

AU - Hohl, Mathias

AU - Dobrev, Dobromir

AU - Linz, Dominik

PY - 2020/10

Y1 - 2020/10

KW - Anticoagulation

KW - Arrhythmia

KW - Inflammasome

KW - Remote monitoring

KW - Thromboembolic risk

KW - OBSTRUCTIVE RESPIRATORY EVENTS

KW - CRITICALLY-ILL PATIENTS

KW - INFLAMMATION

KW - PROMOTES

KW - RECEPTOR

KW - OUTCOMES

KW - ACE2

KW - ARRHYTHMIAS

KW - DYSFUNCTION

KW - AMIODARONE

U2 - 10.1016/j.ijcha.2020.100631

DO - 10.1016/j.ijcha.2020.100631

M3 - Review article

C2 - 32904969

VL - 30

JO - IJC Heart and Vasculature

JF - IJC Heart and Vasculature

SN - 2352-9067

M1 - 100631

ER -